Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients [Phase 3]
Phase 3 trial evaluating prevention and treatment of chemotherapy-induced nausea and vomiting in gynecologic cancer patients treated with th…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating adverse events and changes in disease activity across multiple treatment combinations using mirvetuximab…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated immunotherapy with neo-adjuvant chemotherapy for ovarian cancer.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]
Phase 1 study of TBI-1301, an NY-ESO-1–specific TCR gene-transduced autologous T cell therapy, in solid tumors; the trial is currently activ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers [Phase 1, Phase 2]
Regeneron is conducting a Phase 1/2 trial of REGN4018 (Ubamatamab) alone or in combination with cemiplimab in adults with recurrent MUC16-ex…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations [Phase 2, Phase 3]
The DETERMINE trial update investigates the combination of Trastuzumab and Pertuzumab for HER2-amplified or activating-mutant cancers in adu…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of sacituzumab govitecan in combination with cisplatin for platinum-sensitive recurrent o…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique) [NA]
A clinical trial investigating whether preserving the superior left colic artery improves vascularization of the descending colon prior to c…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This ClinicalTrials.gov entry describes a recruiting USC-led study evaluating social health, activity behaviors, and quality of life among y…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: BRCA Mutation Carriers' Platform a Multicenter Study
A multicenter clinical trial platform for BRCA1 and BRCA2 mutation carriers is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]
A Phase 1 study of BLU-222 in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
EMA withdrawal · 2025-11-27EMA Lapsed: Celdoxome pegylated liposomal (doxorubicin hydrochloride) — Baxter Holding B.V.
EMA notes that the marketing authorization for Celdoxome pegylated liposomal doxorubicin hydrochloride has lapsed, covering breast cancer, o…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial investigating the combination of vismodegib and atezolizumab in platinum-resistant ovarian, fallopian tube, and primary peri…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer [NA]
This clinical trial update describes a comprehensive yoga therapy-based lifestyle prehabilitation program for women with ovarian cancer. The…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. [Phase 2, Phase 3]
Phase 2/3 DETERMINE trial treatment arm 05 is evaluating the combination of vemurafenib and cobimetinib in adults with BRAF-positive cancers…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study of Serum Folate Levels in Patients Treated With Olaparib [Phase 4]
Phase 4 trial evaluating serum folate levels in patients with ovarian or breast cancer treated with olaparib; results are now posted.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating REGN5668 with cemiplimab, cemiplimab plus fianlimab, or ubamatamab in adult women with ovarian cancer,…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas [Phase 2]
Phase 2 study of LN-145 (LN-145-S1) in relapsed or refractory ovarian cancer, triple-negative breast cancer, anaplastic thyroid cancer, oste…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial update evaluating liposomal irinotecan in combination with sintilimab and anlotinib for recurrent or persis…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) [NA]
This clinical trial update notes a completed study evaluating an automated system to culture metastatic circulating tumor cells in embryonat…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Prediction of Ovarian Cancer Histotypes and Surgical Outcome
This update describes a clinical trial investigating histotype prediction in ovarian cancer and the associated surgical outcomes. The study …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. [NA]
MD Anderson Cancer Center is recruiting for a study to identify underserved Texans at hereditary cancer risk using mobile mammography units …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy [NA]
Clinical trial update describing detection of homologous recombination pathway gene mutations in circulating tumor DNA from BRCA-mutated ova…
-
CLINICAL_TRIALS other · 2025-11-18Clinical Trial Update: Platino-resistance in Ovarian Cancer [NA]
This clinical trial update indicates a study addressing platinum resistance in epithelial ovarian cancer is currently recruiting.